Literature DB >> 16546151

Ameliorative effects of dietary caloric restriction on oxidative stress and inflammation in the brain of streptozotocin-induced diabetic rats.

Ngozi H Ugochukwu1, Jessica D Mukes, Cynthia L Figgers.   

Abstract

BACKGROUND: There is a strong association between oxidative stress and inflammation in the pathologies of diabetes. Recent evidence suggests that these phenomena could impair brain function. We investigated the potential role of dietary caloric restriction in ameliorating the effects of both oxidative stress and inflammation in the brain of streptozotocin-induced type 2 diabetic rats.
METHODS: Forty male Wistar rats were subjected to 30% caloric restriction (20 animals) and ad libitum feeding (20 animals) for 9 weeks before the induction of diabetes in 20 animals (10 from each group) by intraperitoneal injection of 35 mg/kg body weight streptozotocin.
RESULTS: Caloric restriction was able to significantly (p>0.05) reduce triglyceride, ROS, IL6, TNF-alpha and body weights in diabetic rats. However, no significant differences were obtained in the antioxidant enzyme (SOD, CAT and GPx) activities except in GPx where caloric restriction increased the levels in both non-diabetic and diabetic rats.
CONCLUSION: Caloric restriction was found to ameliorate the oxidative and inflammatory effects of diabetes in the brain. Non-diabetic rats feeding ad libitum were found to have increased levels of oxidative stress and inflammatory biomarkers and these could, in part, be due to their increased body weights.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16546151     DOI: 10.1016/j.cca.2006.02.003

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

1.  The chronological characteristics of SOD1 activity and inflammatory response in the hippocampi of STZ-induced type 1 diabetic rats.

Authors:  Sun Shin Yi; In Koo Hwang; Dae Won Kim; Jae Hoon Shin; Sung Min Nam; Jung Hoon Choi; Choong Hyun Lee; Moo-Ho Won; Je Kyung Seong; Yeo Sung Yoon
Journal:  Neurochem Res       Date:  2010-10-06       Impact factor: 3.996

Review 2.  Neuroinflammation: a common pathway in CNS diseases as mediated at the blood-brain barrier.

Authors:  Michelle A Erickson; Kenji Dohi; William A Banks
Journal:  Neuroimmunomodulation       Date:  2012-01-11       Impact factor: 2.492

Review 3.  Impact of diet restriction in the management of diabetes: evidences from preclinical studies.

Authors:  Pawan Krishan; Onkar Bedi; Monika Rani
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-12-16       Impact factor: 3.000

Review 4.  The link between iron, metabolic syndrome, and Alzheimer's disease.

Authors:  Edna Grünblatt; Jasmin Bartl; Peter Riederer
Journal:  J Neural Transm (Vienna)       Date:  2010-06-17       Impact factor: 3.575

5.  Oxidative stress in cerebrospinal fluid of patients with aseptic and bacterial meningitis.

Authors:  Charlene Cavalheiro de Menezes; Aracélli Gnatta Dorneles; Rita Leal Sperotto; Marta Medeiros Frescura Duarte; Maria Rosa Chitolina Schetinger; Vania Lúcia Loro
Journal:  Neurochem Res       Date:  2009-02-11       Impact factor: 3.996

6.  Prevention of nicotine and streptozotocin treatment induced circulatory oxidative stress by bis-1,7-(2-hydroxyphenyl)-hepta-1,6-diene-3,5-dione in diabetic rats.

Authors:  Bandugula Venkata Reddy; Jayakumar Sivagama Sundari; Elumalai Balamurugan; Venugopal Padmanabhan Menon
Journal:  Mol Cell Biochem       Date:  2009-05-26       Impact factor: 3.396

7.  Late-onset dementia: a mosaic of prototypical pathologies modifiable by diet and lifestyle.

Authors:  Mark P Mattson
Journal:  NPJ Aging Mech Dis       Date:  2015-09-28

8.  Pioglitazone improves cognitive function via increasing insulin sensitivity and strengthening antioxidant defense system in fructose-drinking insulin resistance rats.

Authors:  Qing-Qing Yin; Jin-Jing Pei; Song Xu; Ding-Zhen Luo; Si-Qing Dong; Meng-Han Sun; Li You; Zhi-Jian Sun; Xue-Ping Liu
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.